Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 22.88
+0.38 (1.69%)
Aug 4, 2026, 2:04 PM CET
Kuros Biosciences AG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 146.06 | 85.16 | 39.91 | 19.45 | 15.15 | |
Revenue Growth | 71.51% | 113.38% | 105.15% | 28.38% | 237.01% |
Cost of Revenue | 18.61 | 15.24 | 11.45 | 7.81 | 4.11 |
Gross Profit | 127.45 | 69.92 | 28.46 | 11.65 | 11.04 |
Selling, General & Admin | 107.95 | 67.81 | 37.78 | 20.97 | 15.41 |
Research & Development | 10.67 | 7.87 | 2.41 | 5.62 | 5.47 |
Other Operating Expenses | -0.13 | -0.13 | -0.29 | -0.39 | -0.23 |
Total Operating Expenses | 118.5 | 75.55 | 39.9 | 26.19 | 20.66 |
Operating Income | 8.95 | -5.63 | -11.44 | -14.54 | -9.62 |
Interest Income | 2.86 | 3.25 | 4.49 | 1.92 | 0.65 |
Interest Expense | -6.79 | -1.39 | -4.68 | -4.67 | -1.52 |
Total Non-Operating Income (Expense) | -3.93 | 1.86 | -0.18 | -2.75 | -0.86 |
Pretax Income | 5.02 | -3.77 | -11.62 | -17.3 | -10.48 |
Provision for Income Taxes | 2.55 | 0.42 | 0.45 | -1.51 | -2.21 |
Net Income | 2.46 | -4.19 | -12.08 | -15.79 | -8.27 |
Earnings From Discontinued Operations | 0.09 | -0.65 | -4.25 | - | - |
Net Income to Common | 2.55 | -4.84 | -16.32 | -15.79 | -8.27 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 38 | 37 | 37 | 34 | 33 |
Shares Outstanding (Diluted) | 41 | 37 | 37 | 34 | 33 |
Shares Change | 11.26% | 1.69% | 7.91% | 3.37% | 34.86% |
EPS (Basic) | 0.07 | -0.13 | -0.45 | -0.47 | -0.25 |
EPS (Diluted) | 0.06 | -0.13 | -0.45 | -0.47 | -0.25 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -2.89 | 2.31 | -10.89 | -8.37 | -6.32 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.07 | 0.06 | -0.30 | -0.25 | -0.19 |
Gross Margin | 87.26% | 82.10% | 71.31% | 59.87% | 72.86% |
Operating Margin | 6.13% | -6.61% | -28.66% | -74.76% | -63.46% |
Profit Margin | 1.69% | -4.92% | -30.26% | -81.15% | -54.59% |
FCF Margin | -1.98% | 2.71% | -27.29% | -43.04% | -41.72% |
EBITDA | 12.32 | -2.66 | -8.17 | -11.48 | -6.46 |
EBITDA Margin | 8.44% | -3.12% | -20.47% | -59.00% | -42.61% |
EBIT | 8.95 | -5.63 | -11.44 | -14.54 | -9.62 |
EBIT Margin | 6.13% | -6.61% | -28.66% | -74.76% | -63.46% |
Effective Tax Rate | 50.91% | -11.06% | -3.89% | 8.73% | 21.07% |